that the proceeds shall be used to support major expenses relating to sponsorships, marketing and operations to be incurred by ICUK; and (b) Primary shares made pursuant to the conversion of loans that

or approximately THB 846.7 million so that the proceeds shall be used to support major expenses relating to sponsorships, marketing and operations to be incurred by ICUK; and (b) Primary shares made

personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling

. The increase of total assets mainly came from increasing in inventories due to revenue growth and increasing in PPE, however, Intangible asset due to be used for the production of products to support

still be necessary to support a more robust growth in domestic demand, which would foster the return of inflation to the target range. The 2018 economic growth is expected to be within a range of 4.0-4.5

the year and from additional government measures to support low-income households, although these may gradually decrease. Private investment was also expected to slow down due partly to a decline in

million from the increase in debentures and the implementation of the new TFRS 16 – Lease implementation of Baht 7,527 million. Shareholders’ Equity As of 31 March 2020, Shareholders’ Equity of Baht 5,175

Company entered into a Sponsor Support Agreement with NBM and EBM to provide financial support in the form of shareholders’ loans or the provision of shareholders guarantee in proportion of investment 10

the impact on private consumption is expected to be eased to some extent by various relief measures being rolled out by the government. The Group has committed to support and operate in accordance with

% 30.1 25.1% Net Profit attributed to Equity Shareholders 118.3 4.3% 104.8 3.9% -13.5 -11.4% Revenues Analysis The Company’s total revenue for the first quarter of 2020 was 2,664.4 million Baht which was a